Zantac (Ranitidine) was once associated with relief from heartburn and gastroesophageal acid disease. However, it is not intended to be used as a quick-acting relief. Zantac has been the go-to treatment for acid reflux and heartburn for almost four decades. Zantac is the best-selling drug in a group of drugs called ranitidine.
Connection Between Zantac and Cancers in the Digestive Tract:
You may be eligible to receive substantial financial compensation if you or your family member have taken Zantac and Ranitidine, or you have been diagnosed with cancer. You just need to 'click here to investigate' the factors that help you in getting the same.
Image Source: Google
The following cancers are being reviewed by our legal team:
- Stomach cancer
- Bladder cancer
- Colon cancer
- Liver cancer
- Breast cancer
- Pancreatic cancer
To begin the legal process leading to your compensation, you would need to file suit against Zantac's makers.
What is Zantac?
Zantac was first developed in 1981 and was a staple in the US market for nearly 40 years. Zantac had already reached $1 billion in annual sales within its first decade of existence. Zantac was once the most popular drug in history.
Generic versions have also impacted Zantac’s sales figures. All information you see here is applicable to Zantac as well as generic versions. Sanofi makes Zantac. Zantac was first taken off the market by Sanofi in October 2019. Anyone who took Zantac may be liable for any cancer they may have. It doesn't matter if the person took Zantac many years ago or no longer uses it.